One of the World’s Largest Independent Core Labs
CoreLab Partners is a leading, independent core lab providing centralized cardiac safety services and medical image assessment solutions for pharmaceutical, biotechnology, and medical device sponsors of Phase I–IV studies. Built on 36+ years of cumulative clinical research experience, CoreLab Partners offers the global drug development industry unparalleled scientific and project services, quality deliverables, dedicated global capabilities, and advanced technologies designed to deliver projects on time and
on budget.
Experience in Japan
CoreLab Partners has extensive experience supporting clinical trials in Japan through our comprehensive medical imaging and cardiac safety services. Our services have been successfully employed directly and indirectly by 28 Japanese bio-pharmaceutical organizations.
Downloadable PDF Japan experience brochures:
Unrivalled Scientific Leadership
CoreLab Partners employs board-certified, subspecialty-trained radiologists, nuclear medicine physicists, oncologists, and cardiologists. Our staff is conversant in all major therapeutic areas, offering trial sponsors an unsurpassed level of in-house medical, scientific, and technical expertise.
Therapeutic and Study Expertise
CoreLab Partners has completed image analysis for clinical studies in a broad range of therapeutic categories including:
- Cardiology
- CNS
- Diabetes
- Diagnostic agents
|
- Musculoskeletal
- Neurology
- Oncology
- Medical device studies
|
Global Experience and Broad Therapeutic Reach
CoreLab Partners’ extensive international experience includes working with a wide array of organizations, across hundreds of Phase I–IV studies in over 70 countries. Our senior staff, working alongside global regulatory authorities, leads the advancement of Thorough QT (TQT) and Intensive QT trial design.
We possess deep experience with oncology, cardiovascular, musculoskeletal, CNS, diagnostic contrast imaging agents, and medical device studies. Our imaging and cardiac safety solutions are performed in a strict quality controlled environment, ensuring good clinical practice (GCP) and compliance with 21 CFR Part 11.
CoreLab Partners successfully completed the first ever
regulatory mandated TQT study in the Asia Pacific Rim and the first
TQT study for a Japanese new drug application (NDA).
Full Range of Modalities, Services, and Equipment Solutions
CoreLab Partners offers sponsors a full range of medical imaging modalities and centralized cardiac safety services, including equipment rental and support for local and global clinical studies.
Imaging Modalities:
- Angiography
- Computed Tomography (CT)
- Dual Energy X-ray Absorptiometry (DXA)
- Magnetic Resonance Imaging (MRI)
- Nuclear Medicine
|
- Positron Emission Tomography (PET)
- PET/CT
- Single Photon Emission Computed Tomography (SPECT)
- Medical Photography
|
Cardiac Safety Services:
- TQT
- Digital Holter
- Automated BP
- ABPM
- Pulse Wave Analysis
|
- Digital ECG
- Paper/Mobile ECG
- Telemedicine
- Consulting
|
|